Related Articles
Combined treatment with ABT-737 and VX-680 induces apoptosis in Bcl-2- and c-FLIP-overexpressing breast carcinoma cells
Curcumin enhances the antitumor effect of ABT-737 via activation of the ROS-ASK1-JNK pathway in hepatocellular carcinoma cells
A‑1210477, a selective MCL‑1 inhibitor, overcomes ABT‑737 resistance in AML
Bcl‑2/Bcl‑xL inhibitor ABT‑737 sensitizes pancreatic ductal adenocarcinoma to paclitaxel‑induced cell death
Effects of ABT‑737 combined with irradiation treatment on uterine cervical cancer cells